Google
BLCO Stock Analysis — BAUSCH + LOMB CORP (Healthcare >> Medical Instruments & Supplies)
BLCO FAQ
What is BLCO's P/E ratio?
BAUSCH + LOMB CORP (BLCO) currently trades at a P/E ratio of -104.62.
What is BLCO's ROE?
BAUSCH + LOMB CORP reports a Return on Equity (ROE) of -2.68%.
What is BLCO's dividend yield?
BAUSCH + LOMB CORP offers a dividend yield of 0.00%.
What is BLCO's Quality Score?
Our AI rates BLCO's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BLCO?
Our AI Timing Score for BLCO is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BLCO belong to?
BAUSCH + LOMB CORP is classified under the Healthcare >> Medical Instruments & Supplies sector on the NYSE exchange
BLCO AI Analysis Summary
Our AI summary for BLCO: BAUSCH + LOMB CORP (NYSE), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of -104.62, ROE of -2.68%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 16.91
Price
-0.08
(-0.47%)
Day Change
|
|
|---|
BLCO, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 16.91 |
| PBV / Sector |
0.94 / 3.37
GREAT
|
| Earning Per Share | -0.48 |
| PE / Sector |
N/A / 44.25
|
| PEG or PE/Growth / Sector |
0.07 / -1.35
GREAT
|
| Average 1M Daily Value |
6.52 M
|
| Average 1W Daily Value |
9.38 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 07:59:33 |
| Symbol | BLCO |
| Name | BAUSCH + LOMB CORP |
| Sector | Healthcare >> Medical Instruments & Supplies |
| Market | NYSE |
| Listed Shares | 357.17 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 6,068.24 / 16,159.14 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4
Phone: 905 695 7700
Website: https://www.bausch.com
Employees: 13,000
Description: Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Instruments & Supplies
Click a bubble to view stock details · Bubble size represents market capitalization share
Top Related Stocks
Stocks in the Same Sector
Healthcare › Medical Instruments & SuppliesAnalysed on the same criteria, ordered by market cap